DXCM
★★★☆☆ WatchtemplateDexCom, Inc.
Healthcare · sector percentile 97
Session move
$83.39
Vol 0.89× avg
76/100 quant · tgt $95.48
RS60 +5.2% vs SPY · ADV$ 348.9M
session 2026-10-06 · Snapshot — not live tape
Since last scan
2026-10-06 → 2026-10-07
- Intel downgraded, Marvell upgraded: Wall Street's top analyst calls
Context only — not a buy/sell signal. Built from scan history and cached news/filings.
Snapshot quote
session 2026-10-06 · scan 2026-10-07 · pushed 10-07 13:42 ET · Regular session (stale)
Show quote fundamentalsHide quote fundamentals
- Last (scan/close)
- $83.39
- Previous close
- $86.90
- Pushed last
- $84.35 (stale) · 10-07 13:42 ET · Regular session
- Session open
- $86.28
- Last session range
- $82.86 – $86.75
- 52-week range
- $54.11 – $92.59
- Session volume
- 3,574,585
- Avg volume (20d)
- 4,009,594
- Market cap
- $31.47B
- PE (TTM)
- 33.09
- Forward PE
- 26.75
- Dividend yield
- 0.00%
- 1y target est.
- $95.48
- Next earnings
- 2026-10-29
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes.
If you put $1,000.00 in
1y ago
$1,262.91
+26%
5y ago
$630.43
−37%
Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.
Market briefing
Curated digest — not a trade signal. Headlines and links as provided by the producer.
- Intel downgraded, Marvell upgraded: Wall Street's top analyst calls
Intel downgraded, Marvell upgraded: Wall Street's top analyst calls
Yahoo · 2026-10-07
- Why Medtronic’s $4 Billion MiniMed Exchange Offer Is Losing Its Allure
The tax-free exchange offer allows Medtronic investors to swap their shares for MiniMed shares held by Medtronic in what Wall Street calls a split-off.
Yahoo · 2026-10-02
- This Stock Could Be the Big Winner Out of Oura’s IPO
Glucose monitoring company DexCom’s investment in Oura values the company at just over $5 billion. Oura is looking to go public at a valuation above $15 billion.
Yahoo · 2026-09-28
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — DXCM scores 75.64/100 (Watch) with revenue growth at 13.1% and a multi-factor profile supporting the current ranking.
- Risks — Key risks for DXCM include valuation compression, sector rotation, and any deterioration in earnings momentum or balance-sheet leverage. Context: cached next earnings 2026-10-29; disclosure reasons form4_single_sell.
- Target Upside — Consensus implied upside is 14.5%. Category 'Watch' suggests monitoring position sizing against the 100-point model thresholds.
Score History
30 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-10-07$83.39−$3.5175.6Watch
- 2026-10-06$86.90+$1.5475.5Watch
- 2026-10-05$85.36−$0.8776.0Watch
- 2026-10-02$86.23−$0.0676.4Watch
- 2026-10-01$86.29−$0.3576.7Watch
- 2026-09-30$86.64−$0.0476.6Watch
- 2026-09-29$86.68+$0.0676.3Watch
- 2026-09-28$86.62−$0.8576.2Watch
- 2026-09-25$87.47−$0.2675.5Watch
- 2026-09-24$87.73−$1.8075.6Watch
- 2026-09-23$89.53+$0.3674.9Watch
- 2026-09-22$89.17−$0.1875.0Watch
- 2026-09-21$89.35+$1.4275.1Watch
- 2026-09-18$87.93+$0.5975.9Watch
- 2026-09-17$87.34+$0.8975.9Watch
- 2026-09-16$86.45+$1.7774.8Watch
- 2026-09-15$84.68+$1.6574.6Watch
- 2026-09-14$83.03−$1.4874.6Watch
- 2026-09-11$84.51+$0.6374.6Watch
- 2026-09-10$83.88−$0.6573.8Watch
- 2026-09-09$84.53−$3.3774.8Watch
- 2026-09-08$87.90$0.0077.6Watch
- 2026-09-07$87.90−$1.8177.6Watch
- 2026-09-04$89.71+$0.0276.8Watch
- 2026-09-03$89.69−$0.4576.8Watch
- 2026-09-02$90.14−$0.9275.8Watch
- 2026-09-01$91.06+$0.2476.0Watch
- 2026-08-31$90.82+$1.5376.4Watch
- 2026-08-28$89.29+$0.3376.6Watch
- 2026-08-27$88.96—77.4Watch
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 54.4%
- vs 20d (z)
- 0.02
- Short vol
- 690,686
- Status
- ok
Squeeze pressure score
full25/100
- Short leg
- 19
- Call leg
- 40
- Activity
- 1.9
- Call vol share
- 40.5%
- PCR (vol)
- 1.47
- Call OI share
- 56.9%
- ATM IV
- 43.1%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
Disclosure score
Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.
Disclosure score
-8
- News
- 0
- Insider
- -8
- Earnings
- 0
Signals below are rule hits from cached filings — Risk / Constructive / Attention. Attention is not a bullish call. Linked chips open the SEC original when available.
Risk (−)
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
Earnings surprise (quant context)
From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.
Last reported surprise +0.4%
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-10-29yahoo_calendar
- Last earnings
- —
- SEC ↗42026-09-30
FORM 4
- SEC ↗42026-09-16
FORM 4
- SEC ↗42026-09-16
FORM 4
- SEC ↗8-K2026-09-14
8-K
- SEC ↗42026-09-14
FORM 4
- SEC ↗42026-09-10
FORM 4
- SEC ↗8-K2026-09-10
8-K
- SEC ↗42026-08-28
FORM 4
- SEC ↗42026-08-25
FORM 4
- SEC ↗42026-08-25
FORM 4
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.